Fitterfly, a health tech startup, raised $12 million in a Series A round led by Amazon Smbhav Venture Fund and Fireside Ventures.

This follows a $3.1 million pre-Series A financing launched in April of last year. The current round brings the startup's total funding to $16.6 million to date. 

The round was also attended by 9 Unicorns, Venture Catalysts, Nihar Parikh of 4point0 Health Ventures, and Sriram Natarajan of Molbio.

The funding will be used by the Mumbai-based business to strengthen its technological stack and branding, as well as expand the scope of its diabetes management digital therapies program, Diabefly.

"This funding will help us strengthen our research, launch new verticals in the heart health space, and grow our customer base by reaching out to people living with diabetes as well as the universe of doctors and organizations in the field of chronic disease management," said Dr. Arbinder Singal, Fitterfly's CEO and Co-Founder.

"We want to provide our clinically proven diabetes and weight control approach to the individuals who need it the most," he continued.

Fitterfly, created in 2016 by Dr. Arbinder Singal and Shailesh Gupta, provides individualized digital treatment programs to provide health results for diabetes, pregnancy, PCOS, and obesity.

According to the business, it has handled over 20,000 patients with a 360-degree care strategy and professionally recommended therapy by over 200 doctors throughout India.

"I've known Arbinder for over a decade, and his expertise as a doctor and serial entrepreneur is tremendously valuable for establishing an influential global firm," said Kanwaljit Singh, Fireside Ventures' Founder and Managing Partner.

This is Amazon Smbhav Venture Fund's first investment in Indian health tech. Amazon has created a $250 million small company fund.